임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
44건 표시
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Arthritis, PsoriaticA Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Non-Muscle Invasive Bladder NeoplasmsA Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Colitis, UlcerativeA Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
협력: 얀센(J&J)
- 3상모집 중단 (진행 중)· Metastatic Castrate-sensitive Prostate CancerA Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Atrial FibrillationA Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
리드: 얀센(J&J) · 협력: BMS
- 3상모집 중단 (진행 중)· Relapsed or Refractory Multiple MyelomaA Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Ischemic Stroke; Ischemic Attack, TransientA Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
리드: 얀센(J&J) · 협력: BMS
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Colitis, UlcerativeA Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Arthritis, JuvenileA Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Advanced or Metastatic Non-small Cell Lung CancerA Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Crohn DiseaseA Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Crohn DiseaseA Long-term Extension Study of Ustekinumab in Pediatric Participants
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Arthritis, PsoriaticGuselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Arthritis, PsoriaticA Study of Guselkumab in Participants With Active Psoriatic Arthritis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Chronic Lymphoid LeukemiaIbrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
협력: 애브비, 얀센(J&J), 로슈
- 3상모집 중단 (진행 중)· Urinary Bladder NeoplasmsA Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· X-Linked Retinitis PigmentosaFollow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Prostatic NeoplasmsA Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Metastatic Castration-sensitive Prostate CancerA Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Prostate CancerCombined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy
협력: 얀센(J&J)
- 3상모집 중단 (진행 중)· Prostatic NeoplasmsA Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Castration-Resistant Prostatic CancerA Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Colitis, UlcerativeA Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
리드: 얀센(J&J)
- 3상모집 중단 (진행 중)· Leukemia, Lymphocytic, Chronic, B-CellA Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
리드: 얀센(J&J)
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.